DO
David Owens, M.D.
Chief Medical Officer, Board of Directors, Scientific Advisory Board
Nexalin TechnologyTherapeutic Areas
Nexalin Technology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nexalin Device | Insomnia | Pivotal Trial |
| NeuroCare® AI Platform | Care Delivery & Management | Launched |
Leadership Team at Nexalin Technology
MW
Mark White
President and Chief Executive Officer, Board of Directors
JV
Justin Van Fleet
Chief Financial Officer
CS
Carolyn Shelton
EVP of Clinical, Quality & Regulatory Affairs
JP
John Patrick Claude
Director of Engineering, Research and Development
LB
Leslie Bernhard
Chairman of the Board, Nominating & Corporate Governance Committee Chairman, Audit Committee Chairman, Compensation Committee
AK
Alan Kazden
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee Chairman
BH
Benjamin Hu, M.D.
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee